Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 5
2017 3
2018 6
2019 8
2020 4
Text availability
Article attribute
Article type
Publication date

Search Results

22 results
Results by year
Filters applied: . Clear all
Page 1
Significance of circulating microRNAs in diabetes mellitus type 2 and platelet reactivity: bioinformatic analysis and review.
Pordzik J, Jakubik D, Jarosz-Popek J, Wicik Z, Eyileten C, De Rosa S, Indolfi C, Siller-Matula JM, Czajka P, Postula M. Pordzik J, et al. Among authors: Eyileten C. Cardiovasc Diabetol. 2019 Aug 30;18(1):113. doi: 10.1186/s12933-019-0918-x. Cardiovasc Diabetol. 2019. PMID: 31470851 Free PMC article. Review.
MicroRNAs fingerprint of bicuspid aortic valve.
Sabatino J, Wicik Z, De Rosa S, Eyileten C, Jakubik D, Spaccarotella C, Mongiardo A, Postula M, Indolfi C. Sabatino J, et al. Among authors: Eyileten C. J Mol Cell Cardiol. 2019 Sep;134:98-106. doi: 10.1016/j.yjmcc.2019.07.001. Epub 2019 Jul 3. J Mol Cell Cardiol. 2019. PMID: 31278905
Stratified Approaches to Antiplatelet Therapies Based on Platelet Reactivity Testing.
Ostrowska M, Kubica J, Adamski P, Kubica A, Eyileten C, Postula M, Toma A, Hengstenberg C, Siller-Matula JM. Ostrowska M, et al. Among authors: Eyileten C. Front Cardiovasc Med. 2019 Dec 3;6:176. doi: 10.3389/fcvm.2019.00176. eCollection 2019. Front Cardiovasc Med. 2019. PMID: 31850373 Free PMC article. Review.
Bioresorbable Vascular Scaffolds-Dead End or Still a Rough Diamond?
Jeżewski MP, Kubisa MJ, Eyileten C, De Rosa S, Christ G, Lesiak M, Indolfi C, Toma A, Siller-Matula JM, Postuła M. Jeżewski MP, et al. Among authors: Eyileten C. J Clin Med. 2019 Dec 7;8(12):2167. doi: 10.3390/jcm8122167. J Clin Med. 2019. PMID: 31817876 Free PMC article. Review.
The Potential Role of Platelet-Related microRNAs in the Development of Cardiovascular Events in High-Risk Populations, Including Diabetic Patients: A Review.
Pordzik J, Pisarz K, De Rosa S, Jones AD, Eyileten C, Indolfi C, Malek L, Postula M. Pordzik J, et al. Among authors: Eyileten C. Front Endocrinol (Lausanne). 2018 Mar 20;9:74. doi: 10.3389/fendo.2018.00074. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 29615970 Free PMC article. Review.
Immune Cells in Cancer Therapy and Drug Delivery.
Eyileten C, Majchrzak K, Pilch Z, Tonecka K, Mucha J, Taciak B, Ulewicz K, Witt K, Boffi A, Krol M, Rygiel TP. Eyileten C, et al. Mediators Inflamm. 2016;2016:5230219. doi: 10.1155/2016/5230219. Epub 2016 Apr 24. Mediators Inflamm. 2016. PMID: 27212807 Free PMC article. Review.
Resistin is a prognostic factor for death in type 2 diabetes.
Kapłon-Cieślicka A, Tymińska A, Rosiak M, Ozierański K, Peller M, Eyileten C, Kondracka A, Pordzik J, Mirowska-Guzel D, Opolski G, Postuła M, Filipiak KJ. Kapłon-Cieślicka A, et al. Among authors: Eyileten C. Diabetes Metab Res Rev. 2019 Feb;35(2):e3098. doi: 10.1002/dmrr.3098. Epub 2018 Dec 13. Diabetes Metab Res Rev. 2019. PMID: 30447052 Clinical Trial.
22 results
Jump to page
Feedback